Moreover, reduced expression of survivin (BIRC5) in ENL treated LNCaP cells further supports the caspase –mediated apoptosis pathways as one of the targets for the lignan action in prostate cancer [35]. This evidence concerns the gene BIRC5 and prostate cancer.